A STUDY OF PREVALENCE OF ISCHEMIC HEART DISEASE IN NONDIABETIC CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY HOSPITAL

Dr. B Anjana, Dr Pankaj Hans

Abstract


Background & Objectives:

This study is undertaken with a view to understanding the prevalence of IHD in non-diabetic CKD population and, analyzing the  risk  factors that are already described to influence the incidence of IHD in  CKD population. Diabetic population has been excluded from the study as Diabetes, alone, irrespective of other risks increases the prevalence of IHD. As recommended by NKF, a timely intervention to reduce Coronary Artery Disease or IHD will surely benefit the patients suffering from CKD.

Objectives of study include:

1.   To assess the prevalence of Ischemic heart disease in non-diabetic chronic kidney disease patients.

2.   To analyze the risk factors influence the prevalence of IHD in CKD population.


Keywords


CHRONIC KIDNEY DISEASE (CKD), ISCHEMIC HEART DISEASE, TERTIARY HOSPITAL

Full Text:

PDF

References


Barrett BJ, Parfrey PS, Morgan J, et al prediction of early death in end stage renal disease patients starting dialysis. Am J Kidney Dis-29:214-222, 1997.

Joki N, Hase H, Nakamura R, Yamaguchi T : ONset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal diseases. Nephrol Dial Transplant 12 : 718-723, 1997.

Braun WE, Phillips DF, Vidt dG, et al; Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 16 : 603 - 607, 1984.

Ibels I.S, Alfrey AC, Huffer WE, et. al. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 1979; 66 ; 790; 796.

Schwarz U, Buzello M, Ritz E, et al .Morphology of coronary atherosclerotic lesions In patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15:218-223.

Goodman WG, Goldin J, Kuizon BD, et al. Coronary artery calcification in young adults with end stage renal disease who are undergoing dialysis, N. Engl J Med 2000s ; 342:1478-1483.

Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients a national study Am J Kidney Dis 1998s/ 31:607-617.

Rostand RG, Kirk KA,Rutsky EA: Dialysis ischaemic heart disease: Insights from coronary angiography. Kidney Int 25 :653-659, 1984.

Hase H, Nakarnura R, Ui K, Yabuki S, Yamaguchi T et al : Article in Japanese, Nippon Jinzo Gakkai Shi, Jun; 35(6) : 751 - 6,1993.

Parfrey PS. Fp;eu RN, Harnett JD, Kent GM. Murray DC, Barre PE : Kidney Int. May 49(5) : 1428- 34 : 1996.

Di Benedetto a., Marelli D., D. Andrea A.: Risk factors and underlying cardiovascular diseases in incident ESRD patients; J Nephrol, 2005 Sep-Oct. 18(5); 592-8.

Longston RD, Presley R, Flanders WD, Mcclellan WM. Georgia Medical care Foundation, Atlanta, georgia 30346. USA. Kidney Int 61:609-614,2003.

Masse M, Hébert MJ, Troyanov S, Vigneault N, Sirois I, Madore F. Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients. Nephrol Dial Transplant 2002;17(3):485-491.


Refbacks

  • There are currently no refbacks.